Telehealth has gone through a major boom-and-bust cycle. One promising stock emerging from the bust is Hims & Hers (HIMS 6.75%). Through nifty marketing and an insurance-circumventing subscription model that delivers medicine directly to your front door, the company is taking a lot of share in the telehealth market. The stock has traded up 449% since going public, and it is up a staggering 158% in the past year.Disruptive innovation helped bring shareholders of Hims & Hers stock major gains. But does that m ...